{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:46:23Z","timestamp":1792320383873,"version":"4.4.0"},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,12,15]]},"DOI":"10.2169\/internalmedicine.1344-18","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T18:50:04Z","timestamp":1533840604000},"page":"3611-3613","source":"Crossref","is-referenced-by-count":16,"title":["Is Severe and Long-lasting Linezolid-induced Optic Neuropathy Reversible?"],"prefix":"10.2169","volume":"57","author":[{"given":"Seul","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Pulmonology, Department of Internal Medicine, College of Medicine, Dong-A University, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Hyoung","family":"Kang","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Internal Medicine, College of Medicine, Dong-A University, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Yeol","family":"Ryu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, College of Medicine, Dong-A University, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jung","family":"Um","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Internal Medicine, College of Medicine, Dong-A University, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mee Sook","family":"Roh","sequence":"additional","affiliation":[{"name":"Department of Pathology, College of Medicine, Dong-A University, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choonhee","family":"Son","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Internal Medicine, College of Medicine, Dong-A University, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis. 2016 Update. 22-32 2016."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Stalker DJ, Jungbluth GL. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. Clin Pharmacokinet 42: 1129-1140, 2003.","DOI":"10.2165\/00003088-200342130-00004"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chang KC, Leung CC, Daley CL. Linezolid for multidrug-resistant tuberculosis - authors' reply. Lancet Infect Dis 13: 16-17, 2013.","DOI":"10.1016\/S1473-3099(12)70272-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sotgiu G, Centis R, D'Ambrosio L, et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J 40: 1430-1442, 2012.","DOI":"10.1183\/09031936.00022912"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Karuppannasamy D, Raghuram A, Sundar D. Linezolid-induced optic neuropathy. Indian J Ophthalmol 62: 497-500, 2014.","DOI":"10.4103\/0301-4738.118451"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Grzybowski A, Zulsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta Ophthalmol 93: 402-410, 2015.","DOI":"10.1111\/aos.12515"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. De Vriese AS, Coster RV, Smet J, et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis 42: 1111-1117, 2006.","DOI":"10.1086\/501356"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rucker JC, Hamilton SR, Bardenstein D, Isada CM, Lee MS. Linezolid-associated toxic optic neuropathy. Neurology 66: 595-598, 2006.","DOI":"10.1212\/01.wnl.0000201313.24970.b8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Libershteyn Y. Ethambutol\/Linezolid Toxic Optic Neuropathy. Optom Vis Sci 93: 211-217, 2016.","DOI":"10.1097\/OPX.0000000000000783"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rho JP, Sia IG, Crum BA, Dekutoski MB, Trousdale RT. Linezolid-associated peripheral neuropathy. Mayo Clin Proc 79: 927-930, 2004.","DOI":"10.4065\/79.7.927"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/24\/57_1344-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T23:49:47Z","timestamp":1544831387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/24\/57_1344-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,15]]},"references-count":10,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1344-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,15]]}}}